Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Aurobindo Pharma in the Drug Discovery & Development Pharma 50

Aurobindo Pharma

Rank: 48

2021 Rank: 43

Hyderabad, India
www.aurobindo.com

2021 Revenues ($USD) : $3,350,857,712
2021 Revenues (foreign currencies) : ₹247,746,000,000
2021 R&D spend : $202,880,634.50
2021 Number of Employees : 21,000
Fiscal Year End : 3/31/2021
Leader : K. Nityananda Reddy, vice chair and managing director

Starting in the late 1980s with a focus on manufacturing semi-synthetic penicillin (SSP), Aurobindo eventually entered the high-margin specialty generic formulations segment. The company also is entering the biosimilars market with the acquisition of Veritaz’s formulations business. Aurobindo also has a large preexisting formulation business focused on international markets. The company exports to more than 155 countries and derives more than 90% of its revenues from international operations. Operating one of the largest R&D facilities in India, Aurobindo also has three R&D centers in the U.S. —BB

Aurobindo

[Image courtesy of Aurobindo Pharma]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50